Previous Page  10 / 11 Next Page
Information
Show Menu
Previous Page 10 / 11 Next Page
Page Background

Page 57

Notes:

Volume 2, Issue 1

Neurosurg

ISSN: 2471-9633

Global Stroke 2017

July 05-06, 2017

Neurodegenerative Disorders and Stroke

July 05-06, 2017 Frankfurt, Germany

4

th

International Conference on

Neurosurg 2017, 2:1

DOI: 10.21767/2471-9633-C1-003

The 10,000 fold effect of retrograde neurotransmission-A new concept for cerebral palsy revival: Use of

nitric oxide donors (intrathecal sodium nitroprusside and oral tadalafil)

Vinod Kumar

Sahara India Medical Institute, India

Introduction:

Nitric-oxide-donors (NODs) [intrathecal sodium nitroprusside (IT SNP)] and oral tadalafil is studied in cerebral

palsy (CP). This work proposes three mechanisms for cerebral palsy cases, which are interrelated for swift physiological recovery. A)

Retrograde neurotransmission: Normal excitatory impulse - at the synaptic level, glutamate activates NMDA receptors, with nitric

oxide synthase (NOS) on the postsynaptic membrane, for further propagation by the calcium-calmodulin complex. Nitric oxide

(NO, produced by NOS) travels backward across the chemical synapse and binds the NO receptor at presynaptic neuron, regulating

anterograde neurotransmission (ANT) via retrograde neurotransmission (RNT). Heme is the ligand-binding site of the NO receptor.

Heme exhibits >10,000-fold higher affinity for NO than for oxygen (10,000-fold effect) and; pathological conditions -normal synaptic

activity, including both ANT and RNT, is absent. NO donors release NO from NOS at the postsynaptic region generates an impulse,

same as under normal conditions. B) Vasospasm: Perforators show vasospastic activity. NO vasodilates it via NO-cAMP pathway.

C) Long-term-potentiation (Ltp): The NO–cGMP-pathway plays a role in LTP at many synapses throughout the CNS and at the

neuromuscular junction for memory/learning.

Materials & Method:

60 random CP - 30 control without NOD or with 5% dextrose superfusion, and 30 patients (irrespective of

etiology) comprised the NOD group in which ITSNP and oral tadalafil 0.2 mg per kg/bo/wt per alternate days for three months was

given. The mean age for superfusion was 3.75 years. Pre- and post-NOD status was monitored by GMFM-66 with videography and

MRI studies.

Results:

The mean increase in GMFM-66 at post seven days was 37.29% and three months 37.15% in the NOD group, than control-

group increase of 0% at seven days or three months.

Conclusion:

NOD (ITSNP boosts up the recovery and oral tadalafil maintains the recovery) acts swiftly in the treatment of CP.

drvinodtewari@gmail.com